Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13091
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShen, Pei-Juanen
dc.contributor.authorBurazin, T Cen
dc.contributor.authorGundlach, Andrew Len
dc.date.accessioned2015-05-16T02:52:21Z
dc.date.available2015-05-16T02:52:21Z
dc.date.issued1995-02-01en
dc.identifier.citationBrain Research. Molecular Brain Research; 28(2): 222-30en
dc.identifier.govdoc7723621en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/13091en
dc.description.abstractNoradrenergic (NAergic) transmission in the rat cerebral cortex has recently been shown to be involved in the regulation of the basal expression of NGFI-A, an immediate early gene (IEG) which encodes a zinc-finger transcription factor. The present study further investigated the role of the NAergic system in mediating cortical IEG expression and possible topographical changes in expression of NGFI-A mRNA in rat forebrain after alpha 1- and alpha 2-adrenoceptor (AR) agonist and antagonist treatment. Expression of c-fos and c-jun, which encode leucine-zipper class transcription factors, was also studied. Male Sprague-Dawley rats were injected intraperitoneally with either an alpha 1-AR agonist (methoxamine, 5 or 10 mg/kg); an alpha 1-AR antagonist (prazosin, 5 mg/kg); an alpha 2-AR agonist (clonidine, 0.5 mg/kg); or an alpha 2-AR antagonist (methoxyidazoxan, 5 mg/kg) and killed after 1 h. IEG mRNA levels were detected by quantitative in situ hybridization histochemistry using 35S-labelled oligonucleotides. High basal levels of NGFI-A mRNA were present in cortical layers IV and VI, hippocampal CA1, piriform cortex, amygdala and caudate putamen. alpha 1-AR agonist and antagonist treatment had essentially no effect on IEG mRNA, despite producing characteristic behavioral and peripheral effects at the doses used. Methoxyidazoxan significantly increased (mean%) NGFI-A mRNA in: cerebral cortex (44); caudate putamen (82); amygdala (92); and CA1 of hippocampus (48), while clonidine significantly decreased NGFI-A mRNA in the various cortical layers to a similar extent (27-37%). Basal c-fos mRNA expression was lower than that for NGFI-A in forebrain areas including cortex, caudate putamen and hippocampus.(ABSTRACT TRUNCATED AT 250 WORDS)en
dc.language.isoenen
dc.subject.otherAnimalsen
dc.subject.otherGene Expressionen
dc.subject.otherGenes, Immediate-Early.geneticsen
dc.subject.otherMaleen
dc.subject.otherPrazosin.pharmacologyen
dc.subject.otherProsencephalon.physiologyen
dc.subject.otherProto-Oncogene Proteins c-jun.geneticsen
dc.subject.otherRatsen
dc.subject.otherRats, Sprague-Dawleyen
dc.subject.otherReceptors, Adrenergic, alpha-1.metabolismen
dc.subject.otherReceptors, Adrenergic, alpha-2.metabolismen
dc.titleNoradrenergic regulation of immediate early gene expression in rat forebrain: differential effects of alpha 1- and alpha 2-adrenoceptor drugs.en
dc.typeJournal Articleen
dc.identifier.journaltitleBrain Research. Molecular Brain Researchen
dc.identifier.affiliationUniversity of Melbourne, Department of Medicine, Austin Hospital, Heidelberg, Australiaen
dc.description.pages222-30en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/7723621en
dc.type.austinJournal Articleen
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
Appears in Collections:Journal articles
Show simple item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.